Bio-Rad Laboratories, Inc. (BIO.B) stock
BIO.BNYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 8/3055% above fair value
$379.50+0.00 (0.00%)
Close on Oct 29, 2026Market cap $10.18BP/E 46.2Yield –
Bio-Rad Laboratories EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Bio-Rad Laboratories's EV/EBITDA was 163.6× on Oct 19, 2026, against 38.9× a year earlier. Over the last 5 years it ranged from 18.0× to 180.4×, with a median of 28.6×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 163.6× | +127.4 |
| 2025 | Dec 31, 2025 | 36.2× | +7.1 |
| 2024 | Dec 31, 2024 | 29.1× | +4.3 |
| 2023 | Dec 29, 2023 | 24.8× | +0.1 |
| 2022 | Dec 30, 2022 | 24.8× | −13.1 |
| 2021 | Dec 31, 2021 | 37.8× | −17.9 |
| 2020 | Dec 31, 2020 | 55.8× | −80.5 |
| 2019 | Dec 31, 2019 | 136.3× | +115.4 |
| 2018 | Dec 31, 2018 | 20.9× | −18.6 |
| 2017 | Dec 29, 2017 | 39.5× | +21.1 |
| 2016 | Dec 30, 2016 | 18.4× | +5.8 |
| 2015 | Dec 31, 2015 | 12.6× | +1.9 |
| 2014 | Dec 31, 2014 | 10.7× | +0.1 |
| 2013 | Dec 31, 2013 | 10.6× | +3.6 |
| 2012 | Dec 31, 2012 | 6.9× | +0.6 |
| 2011 | Dec 30, 2011 | 6.3× | −1.6 |
| 2010 | Dec 31, 2010 | 7.9× | −5.6 |
| 2009 | Dec 31, 2009 | 13.5× | – |